A109960 logo

APTOCROM Inc. Stock Price

KOSDAQ:A109960 Community·₩60.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A109960 Share Price Performance

₩0
-498.00 (-100.00%)
₩0
-498.00 (-100.00%)
Price ₩0

A109960 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet with very low risk.

2 Risks
0 Rewards

APTOCROM Inc. Key Details

₩12.2b

Revenue

₩9.8b

Cost of Revenue

₩2.4b

Gross Profit

₩69.2b

Other Expenses

-₩66.8b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-302.75
19.41%
-549.87%
2.0%
View Full Analysis

About A109960

Founded
1998
Employees
12
CEO
n/a
WebsiteView website
www.aprogen-hng.com

APTOCROM Inc. distributes pharmaceutical products in South Korea. It offers prescription and over-the-counter medication, such as antibiotics, antifungal agent, antiviral drugs, infusion solution, peptic ulcer medication, osteoarthritis treatment, purifying solvent, brain function improvement agent, respiratory solvent, topical medicine, adrenocorticosteroids, urinary medicine, hair loss treatment, antipyretic analgesic and anti-inflammatory agent, antihistamines, obesity agents, neural contract, liver extract, fire extinguisher solvent, etc. The company was formerly known as AP Healthcare Inc. and changed its name to APTOCROM Inc. in September 2025. APTOCROM Inc. was founded in 1998 and is headquartered in Seongnam-si, South Korea.

Recent A109960 News & Updates

Recent updates

No updates